Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Tricuspid TEER | A new recall for heart devices | Next-gen TAVR valve delivers | More from the last week
Saturday, March 18, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

TRILUMINATE trial may pave the way for FDA clearance for tricuspid valve clip device

Paul Sorajja, MD, discusses the late-breaking TRILUMINATE pivotal trial at ACC.23 and how tricuspid TEER performed against the current standard of care using medical therapy.

READ MORE >
Paul Sorajja, MD, director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, was the principal investigator for the late-breaking TRILUMINATE pivotal trial at the American College of Cardiology (ACC) 2023 meeting and explains details of this landmark trial. #ACC #ACC23 #triluminate
Share on Twitter Share on Facebook Share on Linkedin

TRILUMINATE trial may pave the way for FDA clearance for tricuspid valve clip device

Share on Twitter Share on Facebook Share on Linkedin
Paul Sorajja, MD, director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, was the principal investigator for the late-breaking TRILUMINATE pivotal trial at the American College of Cardiology (ACC) 2023 meeting and explains details of this landmark trial. #ACC #ACC23 #triluminate
Paul Sorajja, MD, discusses the late-breaking TRILUMINATE pivotal trial at ACC.23 and how tricuspid TEER performed against the current standard of care using medical therapy.
READ MORE >

FDA announces new Class I recall of troubled heart devices

The recall includes approximately 2,300 devices distributed to customers prior to July 24, 2017. There have been 44 complaints about this issue so far.

READ MORE >
FDA Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new Class I recall of troubled heart devices

Share on Twitter Share on Facebook Share on Linkedin
FDA Recall
The recall includes approximately 2,300 devices distributed to customers prior to July 24, 2017. There have been 44 complaints about this issue so far.
READ MORE >

Key takeaways from the ACC 2023 annual meeting

ACC.23 Program Chair Doug Drachman, MD, explains what he saw as some of the key takeaways from the American College of Cardiology (ACC) 2023 annual meeting.

READ MORE >
ACC 2023 program chair Douglas Drachman, MD, explains the top takeaways from the American College of Cardiology meeting. #ACC #ACC23
Share on Twitter Share on Facebook Share on Linkedin

Key takeaways from the ACC 2023 annual meeting

Share on Twitter Share on Facebook Share on Linkedin
ACC 2023 program chair Douglas Drachman, MD, explains the top takeaways from the American College of Cardiology meeting. #ACC #ACC23
ACC.23 Program Chair Doug Drachman, MD, explains what he saw as some of the key takeaways from the American College of Cardiology (ACC) 2023 annual meeting.
READ MORE >

Data mining helps hospitals identify new patients in need of TAVR, other structural heart procedures

Sponsored by Medtronic

When the ACC and AHA collaborated on new valvular heart disease guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as TAVR. However, an estimated one-third of patients with severe aortic stenosis in the U.S. still lack a guideline-recommended treatment plan.

READ MORE >
When the American College of Cardiology and American Heart Association collaborated on new valvular heart disease (VHD) guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as transcatheter aortic valve replacement (TAVR). However, an estimated one-third of patients with severe aortic stenosis (AS) in the U.S. still lack a guideline-recommended treatment plan, dramatically lowering their chances of survival. Doctor at computer
Share on Twitter Share on Facebook Share on Linkedin

Data mining helps hospitals identify new patients in need of TAVR, other structural heart procedures

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
When the American College of Cardiology and American Heart Association collaborated on new valvular heart disease (VHD) guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as transcatheter aortic valve replacement (TAVR). However, an estimated one-third of patients with severe aortic stenosis (AS) in the U.S. still lack a guideline-recommended treatment plan, dramatically lowering their chances of survival. Doctor at computer
When the ACC and AHA collaborated on new valvular heart disease guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as TAVR. However, an estimated one-third of patients with severe aortic stenosis in the U.S. still lack a guideline-recommended treatment plan.
READ MORE >

Next-generation TAVR valve delivers strong outcomes, reduced PVL after one year

A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.

READ MORE >
The SAPIEN 3 Ultra (S3U) transcatheter heart valve from Edwards Lifesciences. A study presented at ESC Congress 2024 in London, confirmed that TAVR was associated with significantly better outcomes than surgery when treating female patients.
Share on Twitter Share on Facebook Share on Linkedin

Next-generation TAVR valve delivers strong outcomes, reduced PVL after one year

Share on Twitter Share on Facebook Share on Linkedin
The SAPIEN 3 Ultra (S3U) transcatheter heart valve from Edwards Lifesciences. A study presented at ESC Congress 2024 in London, confirmed that TAVR was associated with significantly better outcomes than surgery when treating female patients.
A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.
READ MORE >

Structural heart clinics see key benefits from improved referral tracking

Sponsored by Medtronic

Identifying patients with severe aortic stenosis who could potentially benefit from transcatheter aortic valve replacement (TAVR) is very important—but managing and tracking them over time can be quite a challenge.

READ MORE >
Nurse checking in patient
Share on Twitter Share on Facebook Share on Linkedin

Structural heart clinics see key benefits from improved referral tracking

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
Nurse checking in patient
Identifying patients with severe aortic stenosis who could potentially benefit from transcatheter aortic valve replacement (TAVR) is very important—but managing and tracking them over time can be quite a challenge.
READ MORE >

Mediterranean diet reduces risk of CVD, death among women

The popular diet appears to benefit women even more than it benefits men. 

READ MORE >
The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines
Share on Twitter Share on Facebook Share on Linkedin

Mediterranean diet reduces risk of CVD, death among women

Share on Twitter Share on Facebook Share on Linkedin
The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines
The popular diet appears to benefit women even more than it benefits men. 
READ MORE >

Long-term fasting improves heart-related outcomes for at-risk COVID-19 patients

New research presented at the American College of Cardiology’s annual meeting has shown that long-term intermittent fasting improved outcomes for individuals with COVID-19 who also have a history of heart disease.

READ MORE >
New research presented at the American College of Cardiology’s annual meeting has shown that long-term intermittent fasting improved outcomes for individuals with COVID-19 who also have a history of heart disease. #ACC23
Share on Twitter Share on Facebook Share on Linkedin

Long-term fasting improves heart-related outcomes for at-risk COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
New research presented at the American College of Cardiology’s annual meeting has shown that long-term intermittent fasting improved outcomes for individuals with COVID-19 who also have a history of heart disease. #ACC23
New research presented at the American College of Cardiology’s annual meeting has shown that long-term intermittent fasting improved outcomes for individuals with COVID-19 who also have a history of heart disease.
READ MORE >

Children with autism face higher risk of diabetes, heart disease, dyslipidemia

Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.

READ MORE >
U.S. News & World Report children’s hospitals cardiology heart surgery. SCAI said the Accelerating Kids' Access to Care Act would make it easier for children to access pediatric cardiology specialists in neighboring states when none are in their state, or out-of-state doctors are closer.
Share on Twitter Share on Facebook Share on Linkedin

Children with autism face higher risk of diabetes, heart disease, dyslipidemia

Share on Twitter Share on Facebook Share on Linkedin
U.S. News & World Report children’s hospitals cardiology heart surgery. SCAI said the Accelerating Kids' Access to Care Act would make it easier for children to access pediatric cardiology specialists in neighboring states when none are in their state, or out-of-state doctors are closer.
Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.
READ MORE >

FDA clears new LivaNova heart-lung machine for cardiopulmonary bypass procedures

LivaNova PLC developed the new cardio-pulmonary system based on feedback from more than 300 perfusionists.

READ MORE >
The Livanova Essenz heart-lung perfusion machine for cardiopulmonary bypass surgery is designed with updated workflow efficiency, to capture and record electronic data and to tailor therapy for each patient.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new LivaNova heart-lung machine for cardiopulmonary bypass procedures

Share on Twitter Share on Facebook Share on Linkedin
The Livanova Essenz heart-lung perfusion machine for cardiopulmonary bypass surgery is designed with updated workflow efficiency, to capture and record electronic data and to tailor therapy for each patient.
LivaNova PLC developed the new cardio-pulmonary system based on feedback from more than 300 perfusionists.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme